"
A Phase II Trial of Preoperative Chemoradiotherapy with Oral DPD-Inhibitory Fluoropyrimidines in Patients with Advanced Rectal Cancer"
written by Masanori Hotchi, Hiroshi Okitsu, Murato Miura, Madoka Hamada, Yasuhide Sonaka, Yoh Fukuda, Tsutomu Ando, Shinji Kuratate,
published by
Journal of Cancer Therapy,
Vol.3 No.6A, 2012
has been cited by the following article(s):
|
[1]
|
MRI navigation surgery, including lateral pelvic lymph node dissection following chemoradiotherapy, improves local control and functional preservation of the middle to low rectal cancer
Surgical Oncology,
2024
DOI:10.1016/j.suronc.2024.102093
|
|
|
|
|
[2]
|
A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancer
International Journal of Clinical Oncology,
2021
DOI:10.1007/s10147-021-01868-1
|
|
|
|
|
[3]
|
Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer
Oncology Reports,
2015
DOI:10.3892/or.2015.4196
|
|
|
|